Rhythm Pharmaceuticals, Inc. (RYTM)
90.52
-3.11
(-3.32%)
USD |
NASDAQ |
May 15, 16:00
90.57
+0.05
(+0.06%)
After-Hours: 20:00
Rhythm Pharmaceuticals Shareholders Equity (Quarterly) : 122.91M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 42.16M |
| Sarepta Therapeutics, Inc. | 1.505B |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Biogen, Inc. | 18.65B |
| MannKind Corp. | -59.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 442.32M |
| Total Liabilities (Quarterly) | 319.41M |
| Debt to Equity Ratio | 1.847 |
| Current Ratio | 4.168 |
| Net Debt Paydown Yield | 0.10% |